FindTrial
Sign In

TO STUDY THE EFFECT OF PITUITARY SUPPRESSION WITH GONADOTROPHIN RELEASING HORMONE ANALOGUE ON SERUM VITAMIN D3 LEVEL.

EFFECT OF INJ TRIPTORELIN (Gonadotrophin releasing hormone analogue) ON SERUM 25 HYDROXY VITAMIN D3 LEVEL.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/08/003927
Enrollment
20
Registered
2013-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PELVIC ENDOMETRIOSIS

Interventions

Intervention1: PELVIC ENDOMETRIOSIS UNDERGOING CONSERVATIVE SURGERY (LAPAROSCOPY/ LAPAROTOMY): INJ. TRIPTORELIN 3.75 MG SUBCUTANEOUSLY 2 DOSES- FIRST DOSE ON DAY 2 OR 3 OF THE CYCLE AND SECOND DOSE AF
SECOND DOSE AFTER 28 DAYS. SERUM 25-HYDROXY VITAMIN D3 WILL BE MEASURED AT BASELINE AND AFTER THE SECOND DOSE BUT BEFORE THE THIRD DOSE. Intervention3: GONADOTROPHIN RELEASING HORMONE ANALOGUE INJECTI
SECOND DOSE AFTER 28 DAYS. SERUM 25-HYDROXY VITAMIN D3 WILL BE MEASURED AT BASELINE AND AFTER THE SECOND DOSE BUT BEFORE THE THIRD DOSE.

Sponsors

DR SUDHINDRA MOHAN BHATTACHARYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PELVIC ENDOMETRIOSIS UNDERGOING CONSERVATIVE SURGERY (LAPAROSCOPY/ LAPAROTOMY) FOR DYSMENORRHOEA / INFERTILITY.

Exclusion criteria

Exclusion criteria: 1.NON-ENDOMETRIOTIC CASES. 2. PATIENTS KNOWN TO HAVE BONE DISEASES/ PARATHYROID DISEASES 3. PATIENTS ALREADY GETTING VITAMIN D3 SUPPLEMENTATIONS

Design outcomes

Primary

MeasureTime frame
CHANGE IN SERUM 25 HYDROXY VITAMIN D3 LEVELTimepoint: BASELINE AND AFTER THE SECOND DOSE OF TRIPTORELIN INJECTION.—

Secondary

MeasureTime frame
ANY OTHER SIDE EFFECTS NOTED APART FROM MENOPAUSAL SYMPTOMSTimepoint: AFTER TWO DOSES OF INJ TRIPTORELIN—

Countries

India

Contacts

Public ContactDRSUDHINDRA MOHAN BHATTACHARYA

S.C.DAS MEMORIAL MEDICAL AND RESEARCH CENTER; KPC MEDICAL COLLEGE

drsudhindra54@gmail.com033-24303400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026